Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ccm.2016.11.006 http://scihub22266oqcxt.onion/10.1016/j.ccm.2016.11.006 C5324726!5324726 !28159155     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\28159155 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Clin+Chest+Med 2017 ; 38 (1 ): 127-138 Nephropedia Template TP {{tp|p=28159155 |t=2017. Postviral Complications: Bacterial Pneumonia |pdf=|usr=}}{{28159155 }} gab.com Text Postviral Complications: Bacterial Pneumonia JO: Clin Chest Med http://www.kidney.de/pget.php?&tw=1&pmid=28159155 #FOAvip Secondary bacterial pneumonia after viral respiratory infection remains a significant source of morbidity and mortality. Susceptibility is mediated by a variety of viral and bacterial factors, and complex interactions with the host immune system. Prevention and treatment strategies are limited to influenza vaccination and antibiotics/antivirals respectively. Novel approaches to identifying the individuals with influenza who are at increased risk for secondary bacterial pneumonias are urgently needed. Given the threat of further pandemics and the heightened prevalence of these viruses, more research into the immunologic mechanisms of this disease is warranted with the hope of discovering new potential therapies. Twit Text FOAVip Postviral Complications: Bacterial Pneumonia ????Clin Chest Med http://www.kidney.de/pget.php?&tw=1&pmid=28159155 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28159155 #FOAvip English Wikipedia <ref>{{Cite pmid|28159155 }}</ref> Postviral Complications: Bacterial Pneumonia #MMPMID28159155 Prasso JE ; Deng JC Clin Chest Med 2017[Mar]; 38 (1 ): 127-138 PMID28159155 show ga Secondary bacterial pneumonia after viral respiratory infection remains a significant source of morbidity and mortality. Susceptibility is mediated by a variety of viral and bacterial factors, and complex interactions with the host immune system. Prevention and treatment strategies are limited to influenza vaccination and antibiotics/antivirals respectively. Novel approaches to identifying the individuals with influenza who are at increased risk for secondary bacterial pneumonias are urgently needed. Given the threat of further pandemics and the heightened prevalence of these viruses, more research into the immunologic mechanisms of this disease is warranted with the hope of discovering new potential therapies. |Humans [MESH] |Immunity, Innate/*immunology [MESH] |Influenza, Human/*complications/microbiology/pathology [MESH]Postviral Complications: Bacterial Pneumonia (epmc).pdf DeepDyve Pubget Overpricing